Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Hormone-sensitive Prostate Cancer (mHSPC) × relugolix × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 16 Adenocarcinoma 2 Prostate Adenocarcinoma 1 Pathologic Complete Response 1 Neoplasm, Residual 1 Menorrhagia 1 Leiomyoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡